Evidence map›Paper›PMID 36157092›Full record

ArticleThe International journal of angiology : official publication of the International College of Angiology, Inc2022

Pathophysiology and Management of Pulmonary Embolism.

Ishan K Shah, John M Merfeld, Jimy Chun, Tahir Tak

Open access · bronzeAbstract read
In one paragraph

Article in The International journal of angiology : official publication of the International College of Angiology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Catestatin in Cardiovascular Diseases.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Venous Thromboembolism: Current Insights and Future Directions.The International journal of angiology : official publication of the International College of Angiology, Inc · 2024
    Review
  13. Article
  14. Diagnostic Strategies in Pulmonary Embolism.The International journal of angiology : official publication of the International College of Angiology, Inc · 2024
    Review
  15. Epidemiology, Etiology, and Pathophysiology of Pulmonary Embolism.The International journal of angiology : official publication of the International College of Angiology, Inc · 2024
    Review
  16. Pulmonary Embolism in Donor Lungs-Incidence and Management.The International journal of angiology : official publication of the International College of Angiology, Inc · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ishan K ShahDepartment of Family Medicine, Mayo Clinic Health System, La Crosse, Wisconsin.
John M MerfeldDepartment of Family Medicine, Mayo Clinic Health System, La Crosse, Wisconsin.
Jimy ChunDepartment of Nephrology, Mayo Clinic, La Crosse, Wisconsin.
Tahir TakDepartment of Cardiovascular Diseases, Mayo Clinic Health System, La Crosse, Wisconsin.
Mayo Clinic Health System · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary embolism (PE) is one of the most common etiologies of cardiovascular mortality. It could be linked to several risk factors including advanced age. The pathogenesis of PE is dictated by the Virchow's triad that includes venous stasis, endothelial injury, and a hypercoagulable state. The diagnosis of PE is difficult and is often missed due to the nonspecific symptomatology. Hypoxia is common in the setting of PE, and the degree of respiratory compromise is multifactorial and influenced by underlying cardiac function, clot location, and ability to compensate with respiratory mechanics. Right ventricular dysfunction/failure is the more profound cardiovascular impact of acute PE and occurs due to sudden increase in afterload. This is also the primary cause of death in PE. High clinical suspicion is required in those with risk factors and presenting signs or symptoms of venous thromboembolic disease, with validated clinical risk scores such as the Wells, Geneva, and pulmonary embolism rule out criteria in estimating the likelihood for PE. Advancement in capture time and wider availability of computed tomographic pulmonary angiography and D-dimer testing have further facilitated the rapid evaluation and diagnosis of suspected PE. Treatment is dependent on clinical presentation and initially involves providing adequate oxygenation and stabilizing hemodynamics. Anticoagulant therapy is indicated for the treatment of PE. Treatment is guided by presence or absence of shock and ranges from therapeutic anticoagulation to pharmacologic versus mechanical thrombectomy. The prognosis of patients can vary considerably depending on the cardiac and pulmonary status of patient and the size of the embolus.

Indexed as

deep venous thrombosishypoxiapulmonary angiographypulmonary embolismpulmonary hypertensionthromboembolic diseaseVirchow's triad

Identifiers

PMID36157092
PMCPMC9507564
OpenAlexW4297013943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.